Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AVE-0118 (Synonyms: AVE0118, AVE 0118)

Catalog No. T26689 Copy Product Info
Purity: 98.93%
🥰Excellent
AVE-0118 is a potassium channel blocker and suppresses persistent atrial fibrillation.

AVE-0118

Copy Product Info
🥰Excellent
Catalog No. T26689
Synonyms AVE0118, AVE 0118

AVE-0118 is a potassium channel blocker and suppresses persistent atrial fibrillation.

AVE-0118
Cas No. 498577-53-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$67In StockIn Stock
5 mg$142In StockIn Stock
10 mg$193In StockIn Stock
25 mg$337In StockIn Stock
50 mg$498In StockIn Stock
100 mg$725-In Stock
500 mg$1,520-In Stock
1 mL x 10 mM (in DMSO)$171In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.93%
Color:Yellow to Orange
Contact us for more batch information

Resource Download

Product Introduction

AVE-0118 AI Summary
AVE-0118 inhibits human ERG with an IC50 value of 10000.0 nM. It also shows high plasma protein binding (PPB) across different species, ranging from 83.04% in guinea pigs to 99.34% in humans, indicating a strong affinity for plasma proteins that may affect its pharmacokinetic profile. Additionally, AVE-0118 inhibits human TASK1 when expressed in Xenopus oocytes, as measured by a whole cell voltage clamp assay, with an IC50 value of 600.0 nM. This inhibition of TASK-1 channel current was observed at a +40mV holding potential using a two-electrode voltage clamp assay..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
AVE-0118 is a potassium channel blocker and suppresses persistent atrial fibrillation.
SynonymsAVE0118, AVE 0118
Chemical Properties
Molecular Weight479.57
FormulaC30H29N3O3
Cas No.498577-53-0
SmilesC(NCCC=1C=CC=NC1)(=O)C2=C(C=CC=C2)C3=C(CNC(CC4=CC=C(OC)C=C4)=O)C=CC=C3
Relative Density.1.182 g/cm3 (Predicted)
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (114.69 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0852 mL10.4260 mL20.8520 mL104.2601 mL
5 mM0.4170 mL2.0852 mL4.1704 mL20.8520 mL
10 mM0.2085 mL1.0426 mL2.0852 mL10.4260 mL
20 mM0.1043 mL0.5213 mL1.0426 mL5.2130 mL
50 mM0.0417 mL0.2085 mL0.4170 mL2.0852 mL
100 mM0.0209 mL0.1043 mL0.2085 mL1.0426 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AVE-0118 | purchase AVE-0118 | AVE-0118 cost | order AVE-0118 | AVE-0118 chemical structure | AVE-0118 formula | AVE-0118 molecular weight